Cargando…

The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer

BACKGROUND: This study aimed to develop a novel combined immune score (CIS)-based model assessing prognosis in triple-negative breast cancer (TNBC). METHODS: The expression of eight immune markers (PD-1, PD-L1, PD-L2, IDO, TIM3, OX40, OX40L, and H7-H2) was assessed with immunohistochemistry on the t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Ji Eun, Lee, Jae Seok, Jin, Min-Sun, Nikas, Ilias P., Kim, Kwangsoo, Yang, Sunah, Park, Soo Young, Koh, Jiwon, Yang, Sohyeon, Im, Seock-Ah, Ryu, Han Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625207/ https://www.ncbi.nlm.nih.gov/pubmed/37924153 http://dx.doi.org/10.1186/s13058-023-01710-8

Ejemplares similares

Nicotinamide (niacin) supplement increases lipid metabolism and ROS‐induced energy disruption in triple‐negative breast cancer: potential for drug repositioning as an anti‐tumor agent
por: Jung, Minsun, et al.
Publicado: (2022)

Proteomic-Based Machine Learning Analysis Reveals PYGB as a Novel Immunohistochemical Biomarker to Distinguish Inverted Urothelial Papilloma From Low-Grade Papillary Urothelial Carcinoma With Inverted Growth
por: Jung, Minsun, et al.
Publicado: (2022)

Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer
por: Ha, Dong-Hyeon, et al.
Publicado: (2020)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
por: Rhee, Jiyoung, et al.
Publicado: (2008)

The application of high-throughput proteomics in cytopathology
por: Nikas, Ilias P., et al.
Publicado: (2022)

Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry
por: Park, Yujun, et al.
Publicado: (2021)

Homologous repair deficiency score for identifying breast cancers with defective DNA damage response
por: Min, Ahrum, et al.
Publicado: (2020)

Immune-related biomarkers in triple-negative breast cancer
por: Zhang, Juan, et al.
Publicado: (2021)

Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers
por: Klimov, Sergey, et al.
Publicado: (2017)

High claudin-4 antigen expression in triple-negative breast cancer by the immunohistochemistry method
por: Naimi, Azar, et al.
Publicado: (2022)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
por: Leeha, Marisa, et al.
Publicado: (2023)

Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer
por: Hu, Shaojun, et al.
Publicado: (2021)

Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer
por: Yang, Anli, et al.
Publicado: (2022)

EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer
por: Nikas, Ilias, et al.
Publicado: (2022)

The Role of Nicotinamide in Cancer Chemoprevention and Therapy
por: Nikas, Ilias P., et al.
Publicado: (2020)

Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer
por: Kim, Ji Young, et al.
Publicado: (2017)

Development of an immune-related prognostic biomarker for triple-negative breast cancer
por: Zhang, Yan, et al.
Publicado: (2022)

Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less
por: Kwon, Ji Hyun, et al.
Publicado: (2010)

Lymphocyte-activating gene 3 expression in tumor cells predicts immune checkpoint inhibitor response in triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

Evaluation of triple negative breast cancer with heterogeneous immune infiltration
por: Quintana, Ángela, et al.
Publicado: (2023)

Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I–III breast cancer patients
por: Lee, Dae-Won, et al.
Publicado: (2019)

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma
por: Halse, H., et al.
Publicado: (2018)

Age-related mutational signature negatively associated with immune activity and survival outcome in triple-negative breast cancer
por: Chen, Hao, et al.
Publicado: (2020)

Immunohistochemistry of immune checkpoint markers PD-1 and PD-L1 in prostate cancer
por: Sharma, Meenal, et al.
Publicado: (2019)

Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast Cancer
por: Clark, Curtis A., et al.
Publicado: (2021)

Identification and validation of a combined hypoxia and immune index for triple‐negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2020)

Immune checkpoints: A therapeutic target in triple negative breast cancer
por: Chawla, Akhil, et al.
Publicado: (2014)

Immune responses during neoadjuvant chemotherapy in triple negative breast cancer
por: Ghallab, Ahmed
Publicado: (2020)

Molecular Profiling of Malignant Pleural Effusions with Next Generation Sequencing (NGS): Evidence that Supports Its Role in Cancer Management
por: Grigoriadou, Georgia Ι., et al.
Publicado: (2020)

Inflammation and Immune System Activation in Aging: A Mathematical Approach
por: Nikas, Jason B.
Publicado: (2013)

Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer
por: Hwang, Hye Jung, et al.
Publicado: (2020)

ZDHHC9: a promising therapeutic target for triple-negative breast cancer through immune modulation and immune checkpoint blockade resistance
por: Xu, Chao, et al.
Publicado: (2023)

Correlation Between Immune Cell Infiltration and PD-L1 Expression and Immune-Related lncRNA Determination in Triple-Negative Breast Cancer
por: Yang, Wenlin, et al.
Publicado: (2022)

Reexamination of Dopaminergic Amacrine Cells in the Rabbit Retina: Confocal Analysis with Double- and Triple-labeling Immunohistochemistry
por: Lee, Jong Woo, et al.
Publicado: (2017)

Multiplex immunohistochemistry for immune profiling of HPV-associated head and neck cancer
por: Tsujikawa, Takahiro, et al.
Publicado: (2015)

Understanding immune phenotypes in human gastric disease tissues by multiplexed immunohistochemistry
por: Ying, Le, et al.
Publicado: (2017)

Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment‐naïve patients: A single‐center study
por: Nikas, Ilias P., et al.
Publicado: (2022)

Diagnostic distribution and pitfalls of glandular abnormalities in cervical cytology: a 25-year single-center study
por: Sung, Jung-A, et al.
Publicado: (2022)

Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple‐negative breast cancer to immune checkpoint inhibitors
por: Chen, Xin‐Yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4uiimvt7to3vqcu5meirkv4dvj